Table 4 Treatments and outcome of the 61 BD patients with BCS reported in literature
Date of publication/authors | Number of patients | Anti-coagulation | Cortico-steroids | Immuno-suppressive therapy | Surgery | Endovascular treatment | Outcome | Follow up (months) |
|---|---|---|---|---|---|---|---|---|
1980/ [11] | 1 | 0 | 0 | 0 | 0 | 0 | death | 4 |
1996/ [20] | 1 | 0 | 0 | 0 | 1(thrombectomy) | 0 | death | During surgery |
2000/ [23] | 1 | 0 | 0 | 0 | 0 | 0 | favourable | 180 |
1983/ [13] | 1 | T | 0 | 0 | 0 | 0 | favourable | 72 |
No treatment | 4 | 0 (T, n =1) | 0 | 0 | 1 thrombectomy | 0 | Death n = 2 (50%) | |
1985/ [14] | 1 | 0 | 1 | 1 | 0 | 0 | favourable | 24 |
2002/ [24] | 1 | 0 | 1 | 1 | 0 | 0 | death | 3 |
2007/ [28] | 1 | 0 | 1 | 0 | 0 | thrombolysis (failure) | death | ND |
2007/ [29] | 3 | 0 | 3 | 3 | 0 | 0 | death (n = 2) favourable (n = 1) | 7;7;6 |
No ATCG | 6 | 0 | 6 | 5 | 0 | 0 | Death n = 4 (67%) | |
1983/ [12] | 1 | 1 | 0 | 0 | 1(shunt) | 0 | death | 1 |
1986/ [15] | 1 | 1 | 0 | 0 | 0 | 1 (stent) | favourable | 36 |
1991/ [18] | 1 | 1 | 0 | 0 | 0 | 0 | death | 1.25 |
1990/ [17] | 1 | 1 | 0 | 0 | 0 | 0 | favourable | 24 |
2008/ [30] | 1 | 1 | 0 | 0 | 0 | 0 | death | ND |
ATCG alone | 5 | 5 | 0 | 0 | 1 | 1 | Death n = 3 (60%) | |
1990/ [17] | 3 | 3 (T, n = 1) | 2 | 1 | 2 (shunt) | 0 | death (n = 1) | 30;4;4 |
2002/ [25] | 1 | 1 | 1 | 0 | 1 | 0 | relapse (n = 1) | 60 |
2004/ [26] | 1 | 1 | 1 | 1 | 0 | dilatation and stent | favourable | 0.25 |
2007/ [27] | 4 | 4 | 4 | 4 | 0 | 0 | death (n = 1) | 1;96;48;36 |
2008/ [30] | 6 | 6 | 6 | 2 | 0 | 0 | favourable (n = 6) | 43 |
2011/ [31] | 1 | 1 | 1 | 1 | 0 | 0 | favourable | 1 |
2011/ [32] | 1 | 1 | 1 | 1 | 0 | 0 | alive | 1.5 |
ATCG and IS | 17 | 17 | 16 | 10 | 3 | 1 | Death n = 2 (12%) | |
TOTAL | 32 | ATC 22 (69%) | 22 (69%) | 15 (47%) | 5 (16%) | 3 (9%) | 12 (38%) | 29.7 months |
Thrombolysis 2 (6%) |